Insulet
PODD
#993
Rank
S$26.49 B
Marketcap
$377.72
Share price
1.08%
Change (1 day)
39.85%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.44 Billion

According to Insulet's latest financial reports the company's current earnings are S$1.98 Billion. In 2023 the company made an earning of S$0.34 Billion, an increase over its 2022 earnings that were of S$59.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.44 B29.82%
2023 S$0.34 B481.9%
2022 S$59.02 M-45.24%
2021 S$0.10 B43.35%
2020 S$75.18 M18.51%
2019 S$63.44 M41.16%
2018 S$44.94 M-711.95%
2017 -S$7.35 Million-56.85%
2016 -S$17.03 Million-79.31%
2015 -S$82.29 Million63.85%
2014 -S$50.23 Million31.04%
2013 -S$38.33 Million-21.96%
2012 -S$49.12 Million
2010 -S$46.84 Million-42.38%
2009 -S$81.3 Million-33.56%
2008 -S$0.13 Billion65.93%
2007 -S$73.74 Million209.75%
2006 -S$23.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$5.28 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.18 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.04 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$25.19 B 5,351.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.28 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.10 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$13.90 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA